The company posted revenues of $460.4 million compared to $430.5 million in Q1 2014, beating the average Wall Street estimate of $445.3 million.
Developed for use with Bruker's IVD MALDI Biotyper, the kit is intended to simplify and speed identification of microorganisms in the blood cultures of septic patients.
The method allows researchers to simultaneously analyze the location and structure of glycan modifications on proteins.
The amendment to a 2013 debt financing agreement will increase revolving commitments to $1.3 billion, extend maturity of loans, and adjust interest rates and fees.
With funding from Oxford Nanopore, the lab is building nanopores with fluid lipid bilayer coatings for the analysis of amyloid aggregates and other proteins.
In PNAS this week: epigenetic changes linked with high-altitude pulmonary edema, transcriptome profiling of maize leaf development, and more.
Stanford University researchers are studying top athletes to uncover genes linked to performance.
The UW's Wylie Burke and Dartmouth's Gilbert Welch argue that whole-genome testing may do more harm than good, and a related poll.
In PLOS this week: phylogenetic study of hepatitis E viruses in Swedish moose, recombination sites in the honeybee genome, and more.